Ropes & Gray advised Acumen, and Latham & Watkins advised the underwriters.Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced the pricing of an upsized underwritten public offering of 16,774,193…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
